BioSpace News Archive

Policy

EVIO Labs Massachusetts Announces ISO 17025 Accreditation

Leading cannabis testing company receives accreditation by A2LA

August 2, 2018
·
3 min read
Business

Lockwood CEO, Matthew Schecter, Recognized as one of PharmaVoice 100 Most Inspiring People

Matthew Schecter, Founder and President/CEO of The Lockwood Group (Lockwood) has been recognized by PharmaVoice in their 2018 annual ranking of the 100 Most Inspirational People.

August 2, 2018
·
3 min read
Business

Sangamo Therapeutics Announces Second Quarter 2018 Conference Call and Webcast

Sangamo Therapeutics, Inc. announced that the Company will release its second quarter 2018 financial results after the market closes on Wednesday, August 8, 2018.

August 2, 2018
·
1 min read
Business

Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America

PTC in-licenses regional rights to TEGSEDI™ and WAYLIVRA™ from Akcea

August 2, 2018
·
10 min read
FDA

Certara Software or Services Supported 95% of the US FDA Novel Drug Approvals in First Half of 2018

Modeling and simulation’s positive impact on NDA and BLA approvals through July 1, 2018 has included first use, orphan and priority review drugs for multiple indications

August 2, 2018
·
3 min read
Drug Development

MiMedx Announces Publication Of Phase 2B Clinical Trial Efficacy Data For Micronized dHACM In The Treatment Of Plantar Fasciitis In Foot & Ankle International

Publication in Peer-Reviewed Journal Underscores Statistically Significant Difference Seen in Pain and Foot Function Compared to Control Group

August 2, 2018
·
5 min read
Business

Healthcare Trust of America, Inc. Announces Greenville, SC Medical Office Sale Agreement

The portfolio consists of 16 MOBs totaling approximately 856,000 square feet of GLA located in Greenville, SC.

August 2, 2018
·
5 min read
Drug Development

Karuna Completes $42 Million Series A Financing Round to Advance Selective Muscarinic Receptor Agonist Program into Phase 2 Study

Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul M.D., and other undisclosed investors

August 2, 2018
·
5 min read
Business

Nobilis Health Reports Second Quarter 2018 Financial Results

Nobilis Health Corp. announced its financial results for the second quarter ended June 30, 2018.

August 2, 2018
·
27 min read
Business

MEDNAX Reports Second Quarter GAAP EPS of $0.85; Adjusted EPS of $1.07

Expands Financial and Operational Improvement Targets

August 2, 2018
·
16 min read